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Abstract
Altered protein homeostasis underlies degenerative diseases triggered by misfolded proteins, including spinal and bulbar
muscular atrophy (SBMA), a neuromuscular disorder caused by a CAG/glutamine expansion in the androgen receptor. Here
we show that the unfolded protein response (UPR), an ER protein quality control pathway, is induced in skeletal muscle
from SBMA patients, AR113Q knock-in male mice, and surgically denervated wild-type mice. To probe the consequence of
UPR induction, we deleted CHOP (C/EBP homologous protein), a transcription factor induced following ER stress. CHOP
deficiency accentuated atrophy in both AR113Q and surgically denervated muscle through activation of macroautophagy, a
lysosomal protein quality control pathway. Conversely, impaired autophagy due to Beclin-1 haploinsufficiency decreased
muscle wasting and extended lifespan of AR113Q males, producing a significant and unexpected amelioration of the
disease phenotype. Our findings highlight critical cross-talk between the UPR and macroautophagy, and they indicate that
autophagy activation accentuates aspects of the SBMA phenotype.
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Introduction
Many adult onset neurodegenerative disorders are character-
ized by the accumulation of abnormally folded proteins that self-
associate into soluble oligomeric species or coalesce into insoluble
protein aggregates. Among these disorders are ones caused by
expansions of CAG/glutamine tracts [1,2]. Spinal and bulbar
muscular atrophy (SBMA), a member of this group, is a
progressive neuromuscular disorder caused by an expanded
glutamine tract near the amino terminus of the androgen receptor
(AR) [3]. This mutation leads to hormone-dependent AR
unfolding, and to the predominant loss of lower motor neurons
in the brainstem and spinal cord of affected males. Clinical onset
occurs in adolescence to adulthood and is characterized initially by
muscle cramps and elevated serum creatine kinase [4,5]. These
myopathic features commonly precede muscle weakness, which
inevitably develops as the disease progresses and is most severe in
the proximal limb and bulbar muscles. Late in the course of
disease, the pathologic features of SBMA include loss of motor
neurons in the brainstem and spinal cord and the occurrence of
myopathic and neurogenic changes in skeletal muscle [6,7].
Studies in mouse models have defined several general principles
that guide our understanding of SBMA pathogenesis. Transgenic
over-expression of the expanded glutamine AR leads to disease,
consistent with the notion that toxicity is predominantly mediated
through a gain-of-function mechanism [8,9]. This toxicity is
androgen-dependent in mice and in SBMA patients, an observa-
tion that led to recent clinical trials with anti-androgens [10–12].
To model SBMA in mice, our laboratory used gene targeting to
exchange 1340 bp of mouse Ar exon 1 with human sequence
containing 21 or 113 CAG repeats [13,14]. Mice expressing the
expanded glutamine AR (AR113Q) develop androgen-dependent
neuromuscular and systemic pathology that models SBMA
[14,15], whereas AR21Q males are similar to wild type littermates
[13,14]. In AR113Q mice, denervation and muscle pathology
occur early in life, prior to detectable motor neuron loss, indicating
that neuronal dysfunction or distal axonal degeneration and
myopathy are early disease manifestations. The notion that
pathology arising in muscle contributes to disease is consistent
with findings in transgenic mice in which over-expression of the
wild type AR in skeletal muscle leads to hormone-dependent
myopathy and motor axon loss [16], and with data showing a
rescue of the disease phenotype in SBMA transgenic mice by over-
expressing IGF-1 in skeletal muscle [17]. Taken together, these
observations focused our attention on the role of skeletal muscle in
disease pathogenesis.
The cellular pathways by which the expanded glutamine AR
mediates toxicity are complex and incompletely understood, with
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expression [18–23], alterations in RNA splicing [24], impairments
in axonal transport [25–27] and defects in mitochondrial function
[28]. Toxicity likely results from the cumulative effects of altering a
diverse array of cellular processes, indicating that potential
treatments targeting a single downstream pathway are likely to
be unsuccessful. These findings prompted us to concentrate
instead on understanding the proximal mechanisms that regulate
degradation of the mutant protein. Work in cellular and mouse
models has established that degradation and aggregation of the
polyglutamine AR are regulated by the Hsp90-based chaperone
machinery [29,30], and that manipulating the expression or
function of Hsp70-dependent E3 ubiquitin ligases markedly affects
AR turnover through the ubiquitin-proteasome pathway [31–33].
In addition to the chaperone machinery, other pathways
regulating protein quality control have been implicated in SBMA
pathogenesis. Here we explored the role of the unfolded protein
response (UPR), an integrated signal transduction pathway that
transmits information about protein folding within the ER lumen to
the nucleus and cytosolto regulate protein synthesis and folding and
to influence cell survival [34,35]. Prior studies showed that amino-
terminal fragments of the polyglutamine AR activate the UPR in
vitro [36], but little is known about the role of this pathway in more
complex models of disease. We now show that the UPR is activated
in skeletal muscle from SBMA patients and AR113Q mice.
Moreover, genetic disruption of the ER stress response by deletion
of the gene encoding the transcription factor C/EBP homologous
protein (CHOP), a mediator of the UPR [34], accentuates skeletal
muscle atrophy in AR113Q mice. Further, we show that enhanced
musclewastinginthesettingofCHOPdeficiencyisduetoincreased
macroautophagy (hereafter referred to as autophagy), a lysosomal
protein quality control pathway implicated in the pathogenesis of
polyglutamine and motor neuron diseases. In contrast, diminished
autophagy due to Beclin-1 haploinsufficiency decreased muscle
wasting and extended the lifespan of AR113Q males, unexpectedly
ameliorating the disease phenotype. Our findings highlight cross-
talk between the UPR and autophagy, and demonstrate that
increased autophagy promotes atrophy of SBMA muscle.
Results
The UPR is activated in SBMA muscle
To determine whether the ER stress response is activated in
SBMA we obtained skeletal muscle from patients and male
controls. Gene expression analysis by qPCR demonstrated that
SBMA muscle contained significantly higher levels of several
mRNAs that are induced in response to ER stress (Figure 1A)
[34,35]. These encoded the ER chaperone immunoglobulin
binding protein (BiP), the transcription factors activating tran-
scription factor-4 (ATF4) and its target CHOP, and the ER folding
enzyme protein disulfide isomerase (PDI). Further, increased
splicing of mRNA encoding X-box binding protein-1 (XBP1) was
detected (Figure 1B), indicating that activation of the proximal
UPR sensor inositol-requiring protein-1 (IRE1) had occurred.
Analysis of proximal hind limb muscle from adult AR113Q
male mice similarly demonstrated the induction of mRNAs
encoding BiP, ATF4, CHOP and PDI (Figure 1C). This was
associated with increased expression of BiP and PDI proteins, as
demonstrated by western blot (Figure 1D). As the neuromuscular
phenotype of these mice is both hormone and glutamine-length
dependent [14], we sought to determine whether the occurrence of
ER stress was similarly regulated. Surgical castration at 5–6 wks
ameliorated the induction of these transcripts in adult AR113Q
males, demonstrating that UPR activation was responsive to levels
of circulating androgens (Figure 1C). Further, direct comparison
with mice generated using the same gene targeting strategy but
with only 21 CAG repeats in the Ar gene [13] confirmed that UPR
activation was dependent upon the presence of an expanded
glutamine tract (Figure 1E). In contrast, we did not detect
induction of ER stress-induced mRNAs such as BiP and CHOP in
spinal cords of AR113Q males (Figure 1F), nor did we detect
increased expression of BiP or PDI proteins in spinal motor
neurons (not shown). We conclude that the UPR is activated in
skeletal muscle from SBMA patients and knock-in mice.
CHOP deletion increases AR113Q muscle atrophy and
activates autophagy
As the UPR plays a central role in protein homeostasis in the ER
and influences survival in a cellular model of SBMA [36], we sought
to determine its role in disease pathogenesis in vivo. To accomplish
this, we generated AR113Q males deficient in CHOP, a regulator
of cell survival during ER stress that we found to be up-regulated in
SBMA muscle. CHOP null mice exhibit impaired programmed cell
death following pharmacological induction of ER stress [37].
Further, CHOP deficiency accentuates the phenotype of Pelizaeus-
Merzbacher Disease mice [38] yet rescues the motor deficits of
Charcot-Marie-Tooth 1B mice [39], demonstrating that deletion of
this transcription factor is an informative approach to probing the
role of the UPRin model systems. Notably, CHOP null micedo not
display neuromuscular pathology, thereby enabling us to assess the
outcome of geneticdisruptionof the UPR on the SBMA phenotype.
CHOP deficiency markedly affected AR113Q muscle, the site
of UPR activation, by accentuating skeletal muscle atrophy
(Figure 2A, 2B). This unexpected effect on muscle fiber size
yielded a significant shift in the distribution of fibers towards a
smaller cross sectional area, resulting in a mean fiber size that was
,1/3 smaller than that measured in AR113Q males. In contrast,
CHOP null males expressing the wild type AR had muscle fibers
that were similarly sized to age matched wild type males
(Figure 2C). Although CHOP deficiency did not alter AR113Q
total body mass or survival (not shown), our data show that
disruption of the UPR by CHOP deletion increased muscle
wasting in AR113Q male mice.
Author Summary
In many age-dependent neurodegenerative diseases, the
accumulation of misfolded or mutant proteins drives
pathogenesis. Several protein quality control pathways
have emerged as central regulators of the turnover of
these toxic proteins and therefore impact phenotypic
severity. In spinal and bulbar muscular atrophy (SBMA), the
mutant androgen receptor with an expanded glutamine
tract undergoes hormone-dependent nuclear transloca-
tion, unfolding, and oligomerization—steps that are critical
to the development of progressive proximal limb and
bulbar muscle weakness in men. Here we show that the
unfolded protein response (UPR), an endoplasmic reticu-
lum stress response, is triggered in skeletal muscle from
SBMA patients and knock-in mice. We find that disruption
of the UPR exacerbates skeletal muscle atrophy through
the induction of macroautophagy, a lysosomal protein
quality pathway. In contrast, impaired autophagy dimin-
ishes muscle wasting and prolongs lifespan of SBMA mice.
Our findings highlight cross-talk between the UPR and
autophagy, and they suggest that limited activation of the
autophagic pathway may be beneficial in certain neuro-
muscular diseases such as SBMA where the nucleus is the
essential site of toxicity.
Autophagy Accentuates the Phenotype of SBMA Mice
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increased skeletal muscle atrophy, we initially considered the
possibility that motor neuron degeneration was more severe in
AR113Q mice deficient in CHOP, resulting in enhanced
neurogenic atrophy. However, we found no evidence of increased
motor neuron loss in the spinal cords of these double mutants (not
shown). Furthermore, skeletal muscle expression of mRNAs
induced following denervation [40], including those encoding
myogenin and MyoD, was similar in AR113Q and AR113Q,
CHOP null males (Figure S1). These findings suggested that
enhanced muscle atrophy in animals deficient in CHOP was not
mediated by increased motor neuron loss, but rather reflected
augmented activation of a pathway that mediates muscle wasting.
To directly test this notion, we first examined the expression of
muscle RING-finger protein 1 (MuRF1) and Atrogin1/Muscle
Atrophy F-box (MAFbx) (Figure 3A), two E3 ubiquitin ligases that
are induced in atrophying skeletal muscle and mediate enhanced
protein degradation through the proteasome [41]. While modest
induction of MuRF1 mRNA was observed in AR113Q muscle, its
expression was not further increased by CHOP deficiency. No
significant change in MAFbx expression was detected. Addition-
ally, CHOP deficiency did not alter expression of the 20S
proteasome subunit in skeletal muscle (Figure S2). We conclude
that enhanced atrophy of hind limb muscle in AR113Q, CHOP
null mice was not associated with a significant induction of E3
ligases that promote muscle protein degradation through the
ubiquitin-proteasome pathway.
These findings prompted us to consider the possibility that
another protein degradation pathway underlies the increased
atrophy triggered by CHOP deficiency. As recent studies
demonstrate that autophagy contributes to skeletal muscle wasting
[42], we next examined the activity of the autophagic pathway
following disruption of the UPR. Western blot demonstrated a
,3-fold increase in the autophagosome marker LC3-II (microtu-
bule-associated protein 1, light chain 3-II) in skeletal muscle from
AR113Q, CHOP null mice (Figure 3B). No accumulation of p62
Figure 1. The UPR is activated in SBMA muscle. A. Relative mRNA expression in skeletal muscle from SBMA patients (white bars, n=3) and
controls (black bars, n=3) (mean +/2 SEM). * p,0.05, ** p,0.01 by Student’s t test. B. Splicing of XBP1 mRNA was assessed by RT-PCR. Products from
unspliced (XBP1u) and spliced (XBP1s) transcripts were resolved on a nondenaturing polyacrylamide gel and stained with SYBR green. C. Relative
mRNA expression in proximal hind limb muscle (mean +/2 SEM). Mice evaluated were littermate WT (n=6), AR113Q (n=6), castrated WT (C-WT,
n=6) and castrated AR113Q males (C-AR113Q, n=5) on a mixed C57BL/6J-129 genetic background. *p,0.05 by ANOVA. D. Western blot of BiP and
PDI expression in proximal hind limb muscle. Right panels show quantification of signal relative to loading control (mean +/2 SEM). * p,0.05 by
Student’s t test. E. Relative mRNA expression in proximal hind limb muscle of AR21Q (n=5) and AR113Q (n=3) males backcrossed to C57BL/6J. **
p,0.01, ***p,0.001 by Student’s t test. F. Relative mRNA expression in spinal cord of AR21Q (n=5) and AR113Q (n=3) males (mean +/2 SEM). n.
s.=not significant by Student’s t test.
doi:10.1371/journal.pgen.1002321.g001
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the autophagic pathway was intact following disruption of the UPR.
Consistent with the notion that CHOP deficiency induced autophagy
in AR113Q muscle, we detected increased expression of mRNAs
encoding the autophagy regulators Atg5, Atg9B, LC3B and UVRAG
(Figure 3C). Notably, induction of autophagy was not associated with
altered levels of AR protein (Figure 3D) or the appearance of AR
immunoreactive intranuclear inclusions in skeletal muscle nuclei
(Figure 3E). These observations are consistent with a prior report
demonstrating that the androgen receptor largely escapes autophagic
degradation following its translocation into the nucleus [43], and
indicate that enhanced muscle atrophy in CHOP null mice is
independent of changes in AR protein levels. CHOP deficiency did
not alter phosphorylation of eukaryotic translation initiation factor 2
alpha (eIF2 alpha) or splicing of XBP1 mRNA (Figure 3F), signals
generated by the proximal UPR sensors protein kinase RNA-like ER
kinase (PERK) and IRE1 that have been linked to the regulation of
autophagy [44,45]. In contrast, we observed a modest, but significant
increase in the phosphorylation of c-Jun N-terminal kinases (JNK)
(Figure 3F), suggesting that signaling through JNK may contribute to
enhanced activation of autophagy in AR113Q, CHOP null muscle,
as observed in other systems [46].
CHOP deficiency increases autophagy-induced atrophy
of denervated muscle
Our observation of robust UPR activation in AR113Q skeletal
muscle raised the possibility that muscle denervation induces ER
stress, and that disruption of the UPR by CHOP deficiency
enhances wasting by altering the cellular response to ER stress. To
first test whether denervation is sufficient to activate the UPR in
skeletal muscle, wild type male mice underwent unilateral sciatic
nerve transection, and denervated and intact gastrocnemius
muscles were harvested at 3 or 7 days post surgery. Denervation
significantly increased phosphorylation of eIF2 alpha and splicing
of XBP1 mRNA (Figure 4A) indicating that activation of the
proximal UPR sensors PERK and IRE1 had occurred. Further,
gene expression analysis by qPCR demonstrated a significant
induction of BiP and CHOP mRNAs in denervated muscle, while
ATF4 mRNA levels exhibited a similar trend that failed to reach
statistical significance (Figure 4B). We conclude that denervation
activated the UPR in skeletal muscle.
These results encouraged us to use this system to further explore
the relationship between the UPR and autophagy, and to test the
notion that CHOP deficiency enhances muscle wasting through
the induction of autophagy. Surgical denervation of male mice
expressing the wild type AR demonstrated that CHOP deficiency
significantly increased activity of the autophagic pathway, similar
to our findings in AR113Q muscle. Denervated CHOP null
muscle harvested 7 days post surgery contained ,2.5 fold more
LC3-II than did wild type muscle (Figure 4C). p62 did not
accumulate in CHOP deficient muscle, indicating that flux
through the autophagic pathway was intact. CHOP deficiency
also accentuated skeletal muscle atrophy following denervation,
producing a significant decrease in mean fiber size (Figure 4D).
Our findings demonstrate that CHOP deficiency enhances
autophagy and increases muscle wasting following denervation.
To confirm that autophagy contributes to muscle atrophy
following surgical denervation, we transected the sciatic nerve of
Figure 2. CHOP deletion accentuates muscle atrophy in AR113Q mice. A. Muscle fiber size (100 fibers/mouse) was quantified from proximal
hind limb muscle of AR113Q (black) or AR113Q, CHOP 2/2 mice (white) at 12 wks. Left panel shows fiber size distribution, middle panel shows
cumulative percent of fibers as a function of fiber area, and right panel shows relative fiber cross sectional area (mean +/2 SEM). Left, middle panels,
p,0.0001 by Mann-Whitney test. Right panel, p,0.001 by Student’s t test. B. Representative image of muscle fibers following NADH stain.
Bar=20 mM. C. Distribution of proximal hind limb muscle fiber size from wt (black) and CHOP 2/2 (white) mice at 12 wks. Difference not significant
by Mann-Whitney test.
doi:10.1371/journal.pgen.1002321.g002
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Becn1) is a critical regulator of autophagy that binds class III
phosphoinositide 3-kinase and is both required for the initiation of
autophagosome formation and contributes to autophagosome
maturation [48]. Mice haploinsufficient for Beclin-1 form fewer
autophagosomes in skeletal muscle [49] and therefore allowed us
to probe the role of autophagy in the response of muscle to sciatic
nerve transection. Muscle haploinsufficient for Beclin-1 exhibited
Figure 3. Autophagy is increased in AR113Q, CHOP 2/2 muscle. A. Relative expression of MurRF1 and MAFbx mRNAs in proximal hind limb
muscle of 12 wk mice (n=5–6/genotype). *p,0.05 by ANOVA, n. s.=not significant. B. LC3 and p62 expression in proximal hind limb muscle of 12 wk
mice was assessed by western blot. Right panels show quantification of signal relative to GAPDH. **p,0.01 by Student’s t test. C. Relative expression
of mRNAs encoding autophagy regulators in proximal hind limb muscle. *p,0.05 by Student’s t test. C. Androgen receptor protein expression in
skeletal muscle of 12 wk mice. Hsp90 serves as a loading control. Right panel shows quantification of relative signal intensity (n=3/genotype). D.
Proximal hind limb muscles stained for the androgen receptor (in red) exhibit intranuclear inclusions. Nuclei are stained by DAPI (in blue). E. P-JNK
and P-eIF2 alpha expression (top, middle) and XBP1 mRNA splicing (bottom) in proximal hind limb muscle of 12 wk mice. Right panels show
quantification of signal relative to loading control. **p,0.01 by Student’s t test. n. s.=not significant.
doi:10.1371/journal.pgen.1002321.g003
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type or CHOP null muscle following surgical denervation
(Figure 4D) supporting a role for autophagy in muscle wasting.
To directly test the notion that CHOP deficiency enhanced muscle
wasting by activating autophagy, we generated CHOP null mice
haploinsufficient for Beclin-1 (Figure 4E). Following denervation,
these mice exhibited significantly less atrophy than CHOP null
males, demonstrating that the effects of CHOP deficiency on
muscle wasting were mediated through autophagy.
Beclin-1 haploinsufficiency attenuates the phenotype of
AR113Q males
Our finding that enhanced autophagy triggered by CHOP
deficiency promoted muscle wasting in AR113Q mice prompted
us to determine the consequences of limiting autophagy on the
SBMA phenotype. To accomplish this, we generated AR113Q
males haploinsufficient for Beclin-1. Similar to effects following
surgical denervation, Beclin-1 haploinsufficiency significantly
increased AR113Q muscle fiber size, although in this case the
effect was less robust (Figure 5A). Limiting activity of the
autophagic pathway did not alter levels of either the wild type
or polyglutamine AR protein (Figure 5B), consistent with the
notion that other protein quality control pathways, such as the
proteasome, degrade the receptor once localized to the nucleus.
Despite the limited changes in AR113Q muscle, Beclin-1
haploinsufficiency had a striking effect on survival. The lifespan of
AR113Q males haploinsufficient for Beclin-1 was extended on
average by ,10 wks compared to AR113Q, Beclin-1 wild type
littermates (Figure 6A). AR113Q males exhibited a mean survival
of 21.6 wks; Beclin-1 haploinsufficiency extended mean lifespan by
,44% to 31.1 wks. Lifespan extension was not associated with
rescue to wild type levels of body mass or motor performance as
Figure 4. CHOP deficiency increases denervation-induced atrophy through autophagy. Denervated gastrocnemius muscles or
contralateral intact controls were harvested at the indicated times following unilateral sciatic nerve transection in 6 wk male mice. A. Western blot
shows enhanced eIF2 alpha phosphorylation (top) and RT-PCR demonstrates increased XBP1 mRNA splicing (bottom) in denervated muscle. Right
panels show relative quantification of signal intensity. *p,0.05 by Student’s t test. B. Relative expression of BiP, ATF4 and CHOP mRNA (n=3).
*p,0.05 by Student’s t test. C. Following surgical denervation of wild type or CHOP2/2 mice, LC3 and p62 expression was assessed by western blot.
Right panels show quantification of signal relative to GAPDH. ***p,0.001 by ANOVA, n. s.=not significant. D. Muscle fiber size (100 fibers/mouse)
was quantified from wild type (black, n=5), CHOP 2/2 (white, n=3) and Beclin-1 +/2 (grey, n=3) mice 7 days post sciatic nerve transection. Shown
is relative fiber cross sectional area (mean +/2 SEM). ***p,0.001 by ANOVA. E. Muscle fiber size (100 fibers/mouse) was quantified from CHOP 2/2
(black, n=6) or CHOP 2/2, Beclin-1 +/2 mice (white, n=6) 7 days post sciatic nerve transection. Left panel shows fiber size distribution, middle
panel shows cumulative percent of fibers as a function of fiber area, and right panel shows relative fiber cross sectional area (mean +/2 SEM). Left,
middle panels, p,0.0001 by Mann-Whitney test. Right panel, p,0.001 by Student’s t test.
doi:10.1371/journal.pgen.1002321.g004
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males haploinsufficient for Beclin-1 aged over 20 weeks maintained
motor function while AR113Q, Beclin-1 wild type littermates
exhibited a marked drop-off (Figure 6C). Consistent with the notion
that the effects of Beclin-1 haploinsufficiency on motor function
were most manifest in older mice, we found no change in the age of
diseaseonset (defined asthepoint atwhichgrip strength was 5%less
than controls) due to Beclin-1 haploinsufficiency (Figure 6D). Our
data indicate that Beclin-1 haploinsufficiency significantly extended
the duration of disease by prolonging survival and maintaining
motor function of SBMA mice.
Discussion
The accumulation of misfolded, mutant proteins is a common
basis for adult onset neurodegenerative diseases including those
caused by CAG/glutamine tract expansions [1,2], and pathways
controlling protein homeostasis are central to the cellular response
to these stressors. Here we investigated the role of the UPR, a
regulator of ER protein quality control [34,35], in the pathogen-
esis of SBMA, a neuromuscular disease caused by a glutamine
tract expansion in the AR. Our findings demonstrate the
occurrence of ER stress in skeletal muscle from SBMA patients,
AR113Q mice and wild type mice following surgical denervation.
To identify the functional consequence of this response, we
generated AR113Q mice deficient in the UPR-mediator CHOP, a
transcription factor induced downstream of ATF4 following ER
stress. We show that CHOP deletion accentuates muscle atrophy
in both AR113Q mice and in surgically denervated wild type
males. Notably, in both cases, enhanced muscle wasting due to
CHOP deficiency is mediated by increased autophagy, a lysosomal
protein quality control pathway that has emerged as a central
regulator of proteostasis in several protein aggregation neurode-
generative diseases. While CHOP deficiency activates autophagy
and enhances muscle wasting in SBMA mice, limiting autophagy
by Beclin-1 haploinsufficiency diminishes muscle atrophy, main-
tains motor function in aged animals and markedly extends
lifespan. Our data highlight the central role of the UPR in
remodeling the activity of the protein quality control machinery,
and indicate that robust activation of autophagy accentuates the
muscle atrophy of SBMA.
Activation of the UPR has been reported previously in yeast and
mammalian cell culture models of polyglutamine disease
[36,50,51], and the induction of ER stress responsive transcripts
has been noted in Huntington disease mice [52]. The findings
reported here extend these observations, demonstrating that the
ER stress response is triggered in skeletal muscle from both SBMA
patients and knock-in mice. Further, we define new aspects of the
functional link between the UPR and autophagy. Several
mechanisms by which the UPR regulates autophagy have been
proposed based on studies in mammalian models, but a role for
CHOP has not been identified previously. Data from a cellular
model of polyglutamine disease indicate that phosphorylation of
eIF2 alpha by PERK mediates the induction of LC3-II [45], while
a recent study in cellular and mouse models of superoxide
dismutase 1 (SOD1)-linked ALS show that XBP1 deletion
activates autophagy [44]. As CHOP deficiency altered neither
phosphorylation of eIF2 alpha nor splicing of XBP1 in AR113Q
mice, we suggest that the effects identified here occur through a
distinct mechanism. JNK, a downstream target of IRE1 [53], can
Figure 5. Effects of Beclin-1 haploinsufficiency on AR113Q muscle. A. Muscle fiber size (100 fibers/mouse) was quantified from proximal hind
limb muscle of AR113Q (red, n=6) or AR113Q, Beclin-1 +/2 (blue, n=6) mice at 16 wks. Left panel shows fiber size distribution, and right panel
shows relative fiber cross sectional area (mean +/2 SEM). Left panel, p,0.0001 by Mann-Whitney test. Right panel, p,0.0001 by Student’s t test. B.
AR expression in skeletal muscle of 16 wk mice was assessed by western blot. GAPDH controls for loading. Right panel shows quantification of signal
relative to GAPDH (mean +/2 SEM). Differences not significant (n. s.).
doi:10.1371/journal.pgen.1002321.g005
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increased JNK phosphorylation in AR113Q, CHOP null muscle
raises the possibility that this signaling pathway contributes to
autophagy activation.
The functional consequences of altered autophagy in SBMA
mice were unexpected and suggest that limiting activity of this
pathway is beneficial for certain aspects of the disease phenotype.
As the polyglutamine AR resides in the nucleus in the presence of
ligand and largely escapes degradation through this pathway [43],
we found that soluble and aggregated species of the mutant AR do
not change when mice are deficient in CHOP or haploinsufficient
for Beclin-1. We suggest that this reflects predominant degradation
of the AR by the proteasome, a protein quality control pathway
active in the nucleus. The extension of AR113Q lifespan by
Beclin-1 haploinsufficiency contrasts with findings in Drosophila
showing that disruption of autophagy exacerbates degeneration
when the polyglutamine AR is expressed in the eye [54]. This
difference may reflect variations in the extent to which autophagy
is disrupted, as Beclin-1 haploinsufficiency decreases autophago-
some number but does not completely block this pathway.
Additionally, small molecule activators of autophagy reportedly
promote survival of cultured motor neurons expressing the
polyglutamine AR [43], raising the possibility that the findings
described here in AR113Q mice reflect predominant effects
outside the CNS, such as in skeletal muscle. While activation of
autophagy following UPR disruption exacerbates atrophy of
SBMA muscle in mice, recent studies in SOD1 models of ALS
show that autophagy induction following XBP1 deletion amelio-
rates the disease phenotype [44]. Mutant SOD1, a cytosolic
protein, is a target for autophagic degradation and stimulating this
pathway clears aggregates of the mutant protein.
Of the clinical symptoms experienced by SBMA patients,
muscle wasting is a substantial contributor to morbidity. Here we
show that activation of autophagy significantly enhances atrophy
of surgically denervated and AR113Q muscle. In contrast, limiting
autophagy prolongs lifespan and maintains motor function in
SBMA mice. While the effects of Beclin-1 haploinsufficiency are
relatively mild in AR113Q muscle, lifespan extension is striking,
and likely reflects benefits of limited autophagy in cell types other
than muscle fibers, perhaps including effects on metabolism.
Defining the targets affected by Beclin-1 haploinsufficiency that
mediate lifespan extension remains an important goal for future
work. Notably, strategies to modulate the activity of the
autophagic pathway have attracted considerable attention as
studies in several polyglutamine disease models have documented
degradation of cytoplasmic protein aggregates through autophagy
[55]. Efforts are now underway to identify small molecules that
activate the autophagic pathway in hopes of ameliorating the
phenotypes of these diseases [56,57]. Our data suggest that
autophagy activators are unlikely to be effective therapeutics for
the subset of protein aggregation disorders where nuclear
localization of the mutant protein is required for toxicity.
Furthermore, in SBMA, the effects of disease on muscle may be
accentuated by activation of autophagy. We suggest that
alternative approaches to stimulate other components of the
protein quality control machinery, such as the Hsp90-based
chaperone machinery, are more likely to yield clinical benefits in
SBMA and related protein aggregation disorders.
Materials and Methods
Mice
Derivation of mice with targeted Ar alleles containing 21 or 113
CAG repeats in exon 1 was described previously [14,15]. Briefly,
mice were generated by recombining a portion of human exon 1
encompassing amino acids 31–484 with the mouse Ar gene in CJ7
Figure 6. Beclin-1 haploinsufficiency extends lifespan in AR113Q males. A. Left panel, Kaplan-Meyer survival curve of AR113Q males (red
line, n=12) and AR113Q, Beclin-1 +/2 males (blue line, n=15). *p,0.05 by log-rank analysis. Right panel, mean survival +/2 SEM. *p,0.05 by
Student’s t-test. B, C. Body weight (panel B) and grip strength (panel C) at different ages for wild type (wt, green line, n=7), Beclin-1 +/2 (yellow line
n=9), AR113Q (red line, n=12), and AR113Q, Beclin-1 +/2 (blue line, n=15) male mice. D. Age of disease onset as measured by a decrease of 5% or
more in forelimb grip strength (not significant by log rank analysis).
doi:10.1371/journal.pgen.1002321.g006
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females, and females heterozygous for the targeted Ar allele were
backcrossed to C57BL/6J to generate mice used in this study.
Surgical castration of 5–6 wk old males was as previously
described [14]. Unless otherwise specified, skeletal muscles were
harvested from adult AR113Q male mice at 3–5 months, except
from castrated AR113Q males, in which case animals were 18
months of age. CHOP deficient mice (B6.129S-Ddit3
tm1Dron/J)
[37] were purchased from the Jackson Laboratory and back-
crossed to C57BL/6J ten or more generations. Mice with a Becn1
null allele were previously reported [47] and backcrossed to
C57BL/6J ten or more generations. All procedures involving mice
were approved by the University of Michigan Committee on Use
and Care of Animals, in accord with the NIH Guidelines for the
Care and Use of Experimental Animals.
Sciatic nerve transection
7 wk old C57BL/6J, CHOP deficient or Becn1 haploinsufficient
male mice congenic to C57BL6/J were used for studies of
denervated muscle. Under deep inhaled anesthesia with 2%
isoflurane, the right sciatic nerve was exposed at the thigh just
below the sciatic notch. Both the proximal and distal sides were
ligated with monocryl 4-0 suture, and about 2 mm of sciatic nerve
was cut between the ligations to prevent axonal regeneration. At 3
and 7 days after surgery, the right gastrocnemius and tibialis
anterior muscle were dissected and frozen for histology or RNA
and protein analysis. The contralateral side was used as control.
Human skeletal muscle samples
Anonymized SBMA muscle and control biopsy samples were
obtained from the University of Michigan Medical School in
accordance with IRB procedures and in a manner that assured
patient privacy. Additionally, anonymized skeletal muscle was
harvested from SBMA patients at autopsy, as approved by the
ethics committee of the Nagoya University Graduate School of
Medicine and in accordance with the Declaration of Helsinki
(Hong Kong Amendment).
Muscle fiber size quantification
Muscle was frozen in isopentane chilled by liquid nitrogen, cut
in cross section at a thickness of 5 mm and stained by H&E. Digital
images were captured using a Zeiss Axioplan 2 imaging system.
The area of each muscle fiber was defined using Adobe Photoshop
CS4 or ImageJ, and the pixel number was converted to mm
2
according to scale. 100 adjacent fibers from each section were
measured.
RNA analysis
Total RNA isolated from tissues with Trizol (Invitrogen, Carlsbad,
CA) served as a template for cDNA synthesis using the high capacity
cDNA archive kit from Applied Biosystems (Foster City, CA). Gene-
specific primers and FAM labeled probes (Human: BiP, Hs
99999174_m1; CHOP, Hs99999172_m1; ATF4, Hs00909568_g1;
PDI, Hs00168586_m1; Mouse: BiP, Mm00517691_m1; CHOP,
Mm00492097_m1; ATF4, Mm00515324_m1; PDI: Mm01243184_
m1; MAFbx, Mm00499518_m1; MuRF1, Mm01185221_m1; a-
acetylcholine receptor, Mm00431627_m1; Myod1, Mm00440387_
m1; Myog, Mm00446194_m1; Atg5, Mm00504340_m1; Atg9b,
Mm01157883_g1; Maplc3b, Mm00782868_sH; Uvrag, Mm0072
4370_m1) were purchased from Applied Biosystems. TaqMan assays
were performed in duplicate using 5 ng aliquots of cDNA on an ABI
7500 Real Time PCR system. Relative expression levels were
calculated comparing with the expression of 18S rRNA. Semi-
quantitative RT-PCR analysis of Xbp1 RNA splicing was performed
using primers (mouse: 59-GAACCAGGAGTTAAGAAC-39 and 59-
AGGCAACAGTGTCAGAGT-39;h u m a n :5 9-GAATGAGTGAG-
CTGGAACAG-39 and 59-GAGTCAATACCGCCAGAATC-39)t o
amplify 10 ng of cDNA through 22 cycles. One tenth of the total PCR
products were resolved on 15% nondenaturing polyacrylamide gels
and stained with SYBR Green 1 (Invitrogen, Eugene, OR) after
electrophoresis. Bands were visualized on a Typhoon Trio+ scanner
(Amersham Biosciences, Pistcataway, NJ) and analyzed with AlphaI-
mager 2200 software (Alpha Innotech Corporation, San Leandro,
CA).
Protein expression analysis
Muscle tissue was homogenized in RIPA buffer containing
complete protease inhibitor cocktail (Roche, Indianapolis, IN) and
phosphatase inhibitor (Thermo scientific, Rockford, IL) using a
motor homogenizer (TH115, OMNI International, Marietta, GA).
Sample lysates were incubated on a rotator at 4uC for 1 hour and
the pre-cleared by centrifugation at 15,000 g for 15 minutes at
4uC. Samples were resolved by 7 or 10% SDS-PAGE and
transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA).
Blots were probed with primary antibodies and proteins were
visualized by chemiluminescence (Thermo Scientific, Rockford,
IL). The AR (N-20), HSP90 and eIF2a antibodies were from
Santa Cruz Biotechnology (Santa Cruz, CA), phospho-eIF2a
(Ser51) and phospho-JNK antibodies were from Cell Signaling
Technology (Danvers, MA), LC3B antibody was from Novus
Biologicals (Littleton, CO), GAPDH, BiP and PDI antibodies were
from AbCam (Cambridge, MA), 20S proteasome antibody was
from Calbiochem (Gibbstown, NJ) and p62 antibody was from
American Research Products (Belmont, MA). Western blot
quantification was performed using ImageJ.
Muscle histochemistry and immunofluorescence
Frozen muscle tissue was sectioned at 5 mm with a cryostat and
stained with H&E or NADH. For immunofluorescence, 5 mM
frozen sections were stained with an antibody against AR and an
Alexa Fluor 594 conjugated secondary antibody (Invitrogen).
Confocal images were captured with a Zeiss LSM 510 microscope
and a water immersion lens (663).
Grip strength analysis
The grip strength meter (Columbus Instruments) was positioned
horizontally and mice were lowered toward the apparatus. Mice
were allowed to grasp the smooth metal triangular pull bar with
their fore limbs only, and then were pulled backward in the
horizontal plane. The force applied to the bar at the moment the
grasp was released was recorded as the peak tension (kg). The test
was repeated 5 consecutive times within the same session, and the
highest value from the 5 trials was recorded as the grip strength for
that animal.
Statistics
Statistical significance was assessed by two-tailed Student’s t-test
or by ANOVA with the Newman-Keuls multiple comparison test.
The distribution of muscle fiber size was analyzed by Mann-
Whitney test. All statistics was performed by the Prism 5
(GraphPad Software, San Diego, CA). P values less than 0.05
were considered significant.
Supporting Information
Figure S1 MyoD and myogenin mRNA expression. Relative
expression of MyoD and myogenin mRNAs was determined in
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qPCR. ***p,0.001 by ANOVA, n. s.=not significant.
(TIF)
Figure S2 20S proteasome expression. Western blot shows
expression of 20S proteasome subunit in proximal hind limb
muscle. Lower panel shows relative quantification of signal
intensity. n. s.=not significant.
(TIF)
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